CLINICAL_TRIALS ClinicalTrials.gov record update

A Pilot Study of CDX-301 (rhuFlt3L) With or Without Plerixafor for the Mobilization and Transplantation of Allogeneic Blood Cell Grafts in HLA-Matched Donor/Recipient Sibling Pairs

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02200380
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:37.357264+00:00
Published At: 2017-04-07T00:00:00+00:00
Record Updated At: 2017-04-07
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["For Donors", "Related Donors Giving Peripheral Blood Stem Cells (PBSC) to a Sibling", "For Recipients", "Acute Myelogenous Leukemia (AML)", "Acute Lymphoblastic Leukemia (ALL)", "Myelodysplastic Syndrome (MDS)", "Chronic Myelogenous Leukemia (CML)", "Non-Hodgkins Lymphoma (NHL)", "Hodgkins Disease (HD)", "Chronic Lymphocytic Leukemia (CLL)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-04-07"
protocolSection.identificationModule.nctId: "NCT02200380"
protocolSection.identificationModule.officialTitle: "A Pilot Study of CDX-301 (rhuFlt3L) With or Without Plerixafor for the Mobilization and Transplantation of Allogeneic Blood Cell Grafts in HLA-Matched Donor/Recipient Sibling Pairs"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.